AI Assisted Continuous Flow Electrochemistry for Pharmaceutical Manufacture

人工智能辅助制药制造的连续流电化学

• 批准号: LP230100436
• 负责人: A/Prof Anastasios Polyzos
• 金额: $ 20.76万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2024
• 资助国家: 澳大利亚
• 起止时间: 2024-01-01 至 2025-12-31
• 项目状态: 未结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP230100436
• 关键词: AI; Assisted; Continuous; Flow; Electrochemistry

This project aims to develop new chemical manufacturing processes for pharmaceutical products. In collaboration with Sun Pharma, it will tackle the challenge of replacing expensive and toxic chemicals in industrial reactions, to lower cost of manufacturing and improve its sustainability profile. Central to the realisation of this ambition is the use of electrocatalysis, machine learning and implementation of advanced continuous flow methods. These electricity- and technology-driven reactions will develop new strategies for the generation of important classes of molecules relevant to the Australia’s pharmaceutical sector, as well as their manufacture at industrially relevant scales.

该项目旨在与 Sun Pharma 合作开发新的药品化学制造工艺，解决替代工业反应中昂贵且有毒化学品的挑战，以降低制造成本并改善其可持续发展状况。这一目标是利用电催化、机器学习和先进的连续流方法的实施，这些电力和技术驱动的反应将为澳大利亚制药行业相关的重要分子类别的生成及其制造制定新的策略。在工业相关规模。